Not exact matches
DURECT Corp. is a biopharmaceutical company focused
on two areas of active drug development: New therapeutics based
on its proprietary drug delivery platforms and new chemical entities derived from its
epigenomic regulator program.
Currently, enhancers can be identified through chromatin - based assays, such as ChIP - seq, which predict enhancer elements indirectly based
on the enhancer's association with specific
epigenomic marks, such as transcription factors or molecular tags
on DNA - associated histone proteins.
«This is exactly the technology you could use to look for
epigenomic changes in specific cell types,» says Martienssen, who is also
on the International Human Epigenome Consortium's steering committee.
In a new study published in the journal,
Epigenomics, the researchers focused
on whether a post-weaning diet, or a diet later in life, could control the epigenome and affect metabolism in the body.
Dr Simone Ottonello, from the University of Parma, Italy says: «If extended to black truffles from different geographic areas,
epigenomic analyses, such as the one described in this work, may shed light
on the relationships between DNA methylation and transposon - mediated genome shaping, intraspecific variability and commercially relevant organoleptic traits such as aroma and color»
But
Epigenomics plans to set up a proprietary database
on differences between healthy and diseased tissues to flag, for example, patterns associated with tumors.
Masafumi now leads his own group at the University of Tsukuba in Japan, with a focus
on genomics and
epigenomics of clinical samples.
Genetic data combined with information
on gene expression and
epigenomics in relevant tissues, and clinical information, can provide clues about the effects of genetic changes within an individual's genome that increase or decrease one's risk of developing type 2 diabetes and its complications, including heart and kidney disease.
Epigenomics studies the chemical tags that lie just outside our genes and direct whether particular genes switch
on or off.
Researchers are building a database of DNA sequence, functional and
epigenomic information, and clinical data from studies
on type 2 diabetes and its macro - and microvascular complications, and creating analytic tools to analyze these data.
«The McMurdo Dry Valleys in Antarctica are the closest terrestrial analog we have to what's happening
on other planets,» says David Goerlitz, director of operations for the Genomics and
Epigenomics Shared Resource at Georgetown University Medical Center.
Once finished, however, an
epigenomic map could also prove useful in determining which individuals are at risk for certain diseases and encouraging the kind of lifestyle changes that can prevent the wrong genes from switching
on or off.
In particular, this meeting will focus
on addressing the technological challenges and opportunities presented by the Human Cell Atlas in areas including large - scale single - cell RNA sequencing, spatially - resolved methods, single - cell proteomics,
epigenomics, and sample handling.
His primary research interests are bioinformatics, computational biology, machine learning, and integrative analysis of high throughput sequencing data with an emphasis
on regulatory genomics and
epigenomics.
She is Chair of the Scientific and Medical Advisory Board and serves
on the Board of Trustees of The United Mitochondrial Disease Foundation (UMDF); founding member of the CHOP Center for Mitochondrial and
Epigenomic Medicine (CMEM); CHOP - site PI of the North American Mitochondrial Disease Consortium (NAMDC); member of the Mitochondrial Medicine Society (MMS), Society for Pediatric Research (SPR), Society for Inherited Metabolic Disease (SIMD), American Society of Human Genetics (ASHG), and American College of Medical Genetics and Genomics (ACMGG); and elected member of the University of Pennsylvania John Morgan Society (JMS), Interurban Clinical Club (ICC), and American Society of Clinical Investigators (ASCI).
In particular, this meeting focused
on addressing the technological challenges and opportunities presented by the Human Cell Atlas in areas including large - scale single - cell RNA sequencing, spatially - resolved methods, single - cell proteomics,
epigenomics, and sample handling.
Finally, the explosion of the «omics (microbiomics, genomics and
epigenomics, etc.) and their roles in precision medicine will hopefully be areas of focus that I can bring to bear
on the health of patients through the internal environment, or «milieu».
Lausanne, Switzerland About Blog
Epigenomics and Epigenetics queries the developmental origins of health and disease by cataloguing the sets of physical markings
on chromatin that collaborate to stably alter gene expression.